Business Insider5d
Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
Nov. 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq ... 2024 financial results and reviewed anticipated upcoming program milestones for its portfolio of GeneTAC™ candidates. “Thanks to ...
Cadence Design’s Resilient Growth: Buy Rating Backed by Diversified Portfolio and Strong Valuation Amid Market Challenges
Cadence Design (CDNS – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Lee ...